logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 11 of 11 Items
Showing 1 - 11 of 11 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Letter

Improving access to liposomal amphotericin B worldwide – Authors’ reply

Lee JSF, Sued O, Ribeiro I, Jarvis JN, Burry J
2025-01-01 • Lancet Global Health
2025-01-01 • Lancet Global Health
Journal Article
|
Review

Paving the way for affordable and equitable liposomal amphotericin B access worldwide

Lee JSF, Cohen RM, Khan RA, Burry J, Casas EC,  et al.
2024-09-01 • Lancet Global Health
2024-09-01 • Lancet Global Health
Journal Article
|
Research

A global core outcome measurement set for snakebite clinical trials

Abouyannis M, Esmail H, Hamaluba M, Ngama M, Mwangudzah H,  et al.
2023-02-01 • Lancet Global Health
2023-02-01 • Lancet Global Health
Snakebite clinical trials have often used heterogeneous outcome measures and there is an urgent need for standardisation. A globally representative group of key stakeholders came togethe...
Journal Article
|
Research

Définition d'un jeu universel de critères de décision de base pour les essais cliniques sur les morsures de serpent

Abouyannis M, Esmail H, Hamaluba M, Ngama M, Mwangudzah H,  et al.
2023-02-01 • Médecine tropicale et santé internationale
2023-02-01 • Médecine tropicale et santé internationale
CONTEXTE
Les essais cliniques sur les morsures de serpent ont souvent utilisé des critères de décision hétérogènes qui demandent à être standardisés.

MÉTHODE
Un groupe d...
Journal Article
|
Commentary

Snakebites and COVID-19: two crises, one research and development opportunity

Martins D, Ribeiro I, Potet J
2021-10-25 • BMJ Global Health
2021-10-25 • BMJ Global Health
SUMMARY POINTS

• Despite inherent differences, Snakebite Envenoming and COVID-19 have much in common in terms of research and development (R&D) challenges and opportunities.
Journal Article
|
Commentary

Target product profile (TPP) for Chagas disease point-of-care diagnosis and assessment of response to treatment

Porras AI, Yadon ZE, Altcheh J, Britto C, Chaves GC,  et al.
2015-06-04 • PLOS Neglected Tropical Diseases
2015-06-04 • PLOS Neglected Tropical Diseases
Journal Article
|
Research

Real-Time PCR for the Evaluation of Treatment Response in Clinical Trials of Adult Chronic Chagas Disease: Usefulness of Serial Blood Sampling and qPCR Replicates

Parrado R, Ramirez JC, de la Barra A, Alonso-Vega C, Juiz N,  et al.
2018-12-03 • Antimicrobial Agents and Chemotherapy
2018-12-03 • Antimicrobial Agents and Chemotherapy
This work evaluated a serial blood sampling procedure to enhance the sensitivity of duplex real-time PCR (qPCR) for baseline detection and quantification of parasitic loads and post-trea...
Journal Article
|
Commentary

An unfolding tragedy of Chagas disease in North America

Hotez PJ, Dumonteil E, Cravioto MB, Bottazzi ME, Tapia-Conyer R,  et al.
2013-10-31 • PLOS Neglected Tropical Diseases
2013-10-31 • PLOS Neglected Tropical Diseases
Journal Article
|
Commentary

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries

Loyse A, Burry J, Cohn J, Ford NP, Chiller T,  et al.
2018-10-18 • Lancet Infectious Diseases
2018-10-18 • Lancet Infectious Diseases
In 2018, WHO issued guidelines for the diagnosis, prevention, and management of HIV-related cryptococcal disease. Two strategies are recommended to reduce the high mortality associated w...
Journal Article
|
Research

First external Quality Assurance Program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease

Ramirez JC, Parrado R, Sulleiro E, de la Barra A, Rodriguez M,  et al.
2017-11-27 • PLOS One
2017-11-27 • PLOS One
Real-Time PCR (qPCR) testing is recommended as both a diagnostic and outcome measurement of etiological treatment in clinical practice and clinical trials of Chagas disease (CD), but no ...
Journal Article
|
Commentary

Ending deaths from HIV-related cryptococcal meningitis by 2030

Shroufi A, Chiller T, Jordan A, Denning DW, Harrison TS,  et al.
2021-01-01 • Lancet Infectious Diseases
2021-01-01 • Lancet Infectious Diseases
The UNAIDS target to reduce HIV-related death to fewer than 500 000 deaths per year by 2020 will not be met. 1 This statement might not be headline grabbing as this target was never as p...